Syapse Stock

Syapse enable healthcare providers to deliver the best care to every cancer patient through precision medicine.

About Syapse Stock

Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it.

Funding History

January 2011	$1.6M
January 2013	$3.0M
July 2014	$10.0M
January 2016	$25.0M
November 2017	$30.0M

Management

SVP Product Development

James Lim

Chief Executive Officer

Ken Tarkoff

Founder and President

Jonathan Hirsch

Chief Technology Officer

Tony Loeser

Sr. Product Manager

David Leal

Other Companies

Learn More

CircleCI

Continuous Integration & Delivery Platform

EdgeQ is an information technology company that specializes in the fields of 5G chip systems.

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Vivid Vision uses cutting edge technology to create unique vision tests and treatments.

7Age (years)

$2.9MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Syapse or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 180K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.